These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 23830577)

  • 1. Small molecule inhibition of fibroblast growth factor receptors in cancer.
    Liang G; Chen G; Wei X; Zhao Y; Li X
    Cytokine Growth Factor Rev; 2013 Oct; 24(5):467-75. PubMed ID: 23830577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The potential of fibroblast growth factor/fibroblast growth factor receptor signaling as a therapeutic target in tumor angiogenesis.
    Ronca R; Giacomini A; Rusnati M; Presta M
    Expert Opin Ther Targets; 2015; 19(10):1361-77. PubMed ID: 26125971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FGFR signalling in women's cancers.
    Fearon AE; Gould CR; Grose RP
    Int J Biochem Cell Biol; 2013 Dec; 45(12):2832-42. PubMed ID: 24148254
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fibroblast growth factor receptor signaling in hereditary and neoplastic disease: biologic and clinical implications.
    Helsten T; Schwaederle M; Kurzrock R
    Cancer Metastasis Rev; 2015 Sep; 34(3):479-96. PubMed ID: 26224133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting fibroblast growth factor pathways in endometrial cancer.
    Winterhoff B; Konecny GE
    Curr Probl Cancer; 2017; 41(1):37-47. PubMed ID: 28041631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances and challenges in targeting FGFR signalling in cancer.
    Babina IS; Turner NC
    Nat Rev Cancer; 2017 May; 17(5):318-332. PubMed ID: 28303906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacologically targeting the myristoylation of the scaffold protein FRS2α inhibits FGF/FGFR-mediated oncogenic signaling and tumor progression.
    Li Q; Alsaidan OA; Ma Y; Kim S; Liu J; Albers T; Liu K; Beharry Z; Zhao S; Wang F; Lebedyeva I; Cai H
    J Biol Chem; 2018 Apr; 293(17):6434-6448. PubMed ID: 29540482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Approaches targeting the FGF-FGFR system: a review of the recent patent literature and associated advanced therapeutic agents.
    Herbert C; Lassalle G; Alcouffe C; Bono F
    Pharm Pat Anal; 2014; 3(6):585-612. PubMed ID: 25489913
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast Growth Factor (FGF) Receptor/FGF Inhibitors: Novel Targets and Strategies for Optimization of Response of Solid Tumors.
    Hierro C; Rodon J; Tabernero J
    Semin Oncol; 2015 Dec; 42(6):801-19. PubMed ID: 26615127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Functional Genetic Screen Identifies the Phosphoinositide 3-kinase Pathway as a Determinant of Resistance to Fibroblast Growth Factor Receptor Inhibitors in FGFR Mutant Urothelial Cell Carcinoma.
    Wang L; Šuštić T; Leite de Oliveira R; Lieftink C; Halonen P; van de Ven M; Beijersbergen RL; van den Heuvel MM; Bernards R; van der Heijden MS
    Eur Urol; 2017 Jun; 71(6):858-862. PubMed ID: 28108151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development and ligand-protein interaction of small molecule anti-tumor FGFR inhibitors].
    Li XL; Qiu R; Li J; Hai L; Wu Y
    Yao Xue Xue Bao; 2016 Nov; 51(11):1689-97. PubMed ID: 29908111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isoforms of receptors of fibroblast growth factors.
    Gong SG
    J Cell Physiol; 2014 Dec; 229(12):1887-95. PubMed ID: 24733629
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fibroblast growth factors (FGFs) in cancer: FGF traps as a new therapeutic approach.
    Presta M; Chiodelli P; Giacomini A; Rusnati M; Ronca R
    Pharmacol Ther; 2017 Nov; 179():171-187. PubMed ID: 28564583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting molecular pathways in endometrial cancer: a focus on the FGFR pathway.
    Lee PS; Secord AA
    Cancer Treat Rev; 2014 May; 40(4):507-12. PubMed ID: 24332498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FGFR-targeted therapeutics for the treatment of breast cancer.
    De Luca A; Frezzetti D; Gallo M; Normanno N
    Expert Opin Investig Drugs; 2017 Mar; 26(3):303-311. PubMed ID: 28121208
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting fibroblast growth factor receptor in breast cancer: a promise or a pitfall?
    Bedussi F; Bottini A; Memo M; Fox SB; Sigala S; Generali D
    Expert Opin Ther Targets; 2014 Jun; 18(6):665-78. PubMed ID: 24833241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting the fibroblast growth factor receptor family in cancer.
    Hallinan N; Finn S; Cuffe S; Rafee S; O'Byrne K; Gately K
    Cancer Treat Rev; 2016 May; 46():51-62. PubMed ID: 27109926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the estrogen receptor and fibroblast growth factor receptor pathways in non-small cell lung cancer.
    Siegfried JM; Farooqui M; Rothenberger NJ; Dacic S; Stabile LP
    Oncotarget; 2017 Apr; 8(15):24063-24076. PubMed ID: 28445992
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of FGFR signaling by PD173074 improves antitumor immunity and impairs breast cancer metastasis.
    Ye T; Wei X; Yin T; Xia Y; Li D; Shao B; Song X; He S; Luo M; Gao X; He Z; Luo C; Xiong Y; Wang N; Zeng J; Zhao L; Shen G; Xie Y; Yu L; Wei Y
    Breast Cancer Res Treat; 2014 Feb; 143(3):435-46. PubMed ID: 24398778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Future applications of FGF/FGFR inhibitors in cancer.
    Ghedini GC; Ronca R; Presta M; Giacomini A
    Expert Rev Anticancer Ther; 2018 Sep; 18(9):861-872. PubMed ID: 29936878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.